Lavender inhalation for anxiety, sleep quality, and blood pressure in people with primary hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This double-blind, randomized controlled trial will recruit patients with primary hypertension from the Cardiology Outpatient Clinic at Ardahan State Hospital. Participants are randomized to an experimental group receiving 12 lavender oil inhalation sessions (three times weekly for one month) or to a control group receiving routine care. Outcomes include anxiety measured by the Beck Anxiety Inventory, sleep quality measured by the Pittsburgh Sleep Quality Index, and blood pressure recorded via the Hypertension Diagnostic Form. Statistical comparisons between groups will determine whether lavender inhalation produces changes in these measures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with primary hypertension
* Willing to participate in the study
* No allergy to lavender
* No olfactory impairments
* No history of psychiatric disorders

Exclusion Criteria:

* Communication difficulties
* Unwilling to participate
* Using other herbal or aromatherapy treatments
* History of sleep disorders affecting sleep quality (e.g., obstructive sleep apnea)
* Secondary hypertension or other chronic diseases
* Pregnant or breastfeeding
* Use of tobacco products

Where it's running

• Ardahan State Hospital
  Ardahan, Ardahan, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Derya ŞİMŞEKLİ, PhD
• Email: deryasimsekli@ardahan.edu.tr
• Phone: +905545965789

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endothelial extracellular vesicles in kids with newly diagnosed high blood pressure

  This study tests whether levels of endothelial extracellular vesicles are different in children with new, untreated primary hypertension compared to normotensive children.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728643

• Self- Acupressure for Blood Pressure and Well-Being in Hypertension

  In adults with primary hypertension, this trial tests whether nurse-guided self-acupressure at four points can help lower blood pressure and improve stress and well-being over two weeks, compared with sham or usual care.

  Recruiting Abant Izzet Baysal University · Center, Düzce · NCT07577973

• Dietary nitrate, oral bacteria, and blood pressure in children with primary hypertension

  We will test whether differences in mouth bacteria and how saliva handles dietary nitrate are linked to blood pressure in 10–18-year-olds with primary hypertension compared with healthy peers.

  Recruiting Istanbul University · Istanbul, Fatih · NCT07236125

• SLT versus daily latanoprost to lower eye pressure in early to moderate open‑angle glaucoma and ocular hypertension

  This trial will test whether a one‑time selective laser trabeculoplasty (SLT) or daily 0.005% latanoprost eye drops better lower eye pressure in treatment‑naïve adults with early to moderate primary open‑angle glaucoma or ocular hypertension.

  Recruiting Lagos State Health Service Commission · Ikeja, Lagos · NCT07310719

• Direct selective laser trabeculoplasty to lower eye pressure in untreated open-angle glaucoma

  This study will try direct selective laser trabeculoplasty (DSLT) to lower eye pressure by more than 20% without glaucoma medications over six months in adults newly diagnosed with open-angle glaucoma or ocular hypertension.

  Recruiting Shafer Vision Institute · Plymouth Meeting, Pennsylvania · NCT07076303

• Yufeng Ningxin for High Blood Pressure in Adults

  This study tests whether Yufeng Ningxin tablets can lower blood pressure in adults with essential hypertension compared with a placebo.

  Recruiting at 12 sites Phase 4 Beijing Anzhen Hospital · Beijing and 15 other locations · NCT07607275

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.